相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autoimmune Pancreatitis: Optimal Therapy Has Not Been Determined
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis
Mark Topazian et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Treatment of Primary Biliary Cirrhosis: Therapy with Choleretic and Immunosuppressive Agents
Marina G. Silveira et al.
CLINICS IN LIVER DISEASE (2008)
Safety issues in the management of autoimmune hepatitis
Albert J. Czaja
EXPERT OPINION ON DRUG SAFETY (2008)
The natural history of small-duct primary sclerosing cholangitis
Einar Bjornsson et al.
GASTROENTEROLOGY (2008)
Immunoglobulin G4-associated cholangitis: Clinical profile and response to therapy
Amaar Ghazale et al.
GASTROENTEROLOGY (2008)
Autoimmune pancreatitis
Timothy B. Gardner et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2008)
Long-term follow-up of antimitochondrial antibody - Positive autoimmune hepatitis
Conor O'Brien et al.
HEPATOLOGY (2008)
Simplified criteria for the diagnosis of autoimmune hepatitis
Elke M. Hennes et al.
HEPATOLOGY (2008)
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2008)
New insights into autoimmune liver diseases
Teru Kumagi et al.
HEPATOLOGY RESEARCH (2008)
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
Shinji Iwasaki et al.
HEPATOLOGY RESEARCH (2008)
A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis
Daan W. Hommes et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Gallbladder disease in patients with primary sclerosing cholangitis
Karouk Said et al.
JOURNAL OF HEPATOLOGY (2008)
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Marina G. Silveira et al.
JOURNAL OF HEPATOLOGY (2008)
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
Susan N. Cullen et al.
JOURNAL OF HEPATOLOGY (2008)
The challenges in primary sclerosing cholangitis - Aetiopathogenesis, autoimmunity, management and malignancy
Tobias J. Weismueller et al.
JOURNAL OF HEPATOLOGY (2008)
Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic
Yinka K. Davies et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Preventative hepatology: minimising symptoms and optimising care
Gideon M. Hirschfield et al.
LIVER INTERNATIONAL (2008)
Primary biliary cirrhosis
Teru Kumagi et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
IgG4-related sclerosing disease
Terumi Kamisawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Overlap syndromes among autoimmune liver diseases
Christian Rust et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Mortality attributable to cholestatic liver disease in the United States
Flavia D. Mendes et al.
HEPATOLOGY (2008)
Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging
Rupert Abdalian et al.
HEPATOLOGY (2008)
The causes of primary biliary cirrhosis: Convenient and inconvenient truths
M. Eric Gershwin et al.
HEPATOLOGY (2008)
The impact of ethnicity on the natural history of autoimmune hepatitis
Sumita Verma et al.
HEPATOLOGY (2007)
Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment
Kenji Hirano et al.
GUT (2007)
Optimising corticosteroid treatment for autoimmune pancreatitis
Amaar Ghazale et al.
GUT (2007)
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis
Patrick S. C. Leung et al.
HEPATOLOGY (2007)
Transplantation trends in primary biliary cirrhosis
Jarone Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Autoimmune pancreatitis: Clinical and radiological features and objective response to steroid therapy in a UK series
Nicholas I. Church et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis
Keith Lindor
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Azithromycin may reduce cholestasis in primary sclerosing cholangitis: A case report and serendipitous observation
A. L. Boner et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)
Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease
Aldo J. Montano-Loza et al.
HEPATOLOGY (2007)
Autoimmune diseases of the liver, autoimmune hepatitis and primary biliary cirrhosis: Unfinished business
Ian R. Mackay
HEPATOLOGY RESEARCH (2007)
Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: A population-based cohort study
Hannah Jackson et al.
HEPATOLOGY (2007)
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid
Tatjana Stojakovic et al.
HEPATOLOGY (2007)
Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis
Philippe Ichai et al.
LIVER TRANSPLANTATION (2007)
Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis
Fin Stolze Larsen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid
Gerda Rudolph et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Immunoglobulin G4 associated cholangitis:: Description of an emerging clinical entity based on review of the literature
Einar Bjornsson et al.
HEPATOLOGY (2007)
Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse
Aldo J. Montano-Loza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Consequences of treatment withdrawal in type 1 autoimmune hepatitis
Aldo J. Montano-Loza et al.
LIVER INTERNATIONAL (2007)
Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic HISORt criteria
Suresh T. Chari
JOURNAL OF GASTROENTEROLOGY (2007)
The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis
S. Meagher et al.
ENDOSCOPY (2007)
Autoimmune hepatitis among fertile women: Strategies during pregnancy and breastfeeding?
Marten Werner et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis
Hideaki Hamano et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Follow-up of children with autoimmune hepatitis treated with cyclosporine
Miriam Cuarterolo et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Sclerosing cholangitis: A focus on secondary causes
Rupert Abdalian et al.
HEPATOLOGY (2006)
Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AM followed at a tertiary referral centre
Thawab Al-Chalabi et al.
JOURNAL OF HEPATOLOGY (2006)
Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis
Flavia D. Mendes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients
Pieter C. J. ter Borg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Primary sclerosing cholangitis: Summary of a workshop
Nicholas F. LaRusso et al.
HEPATOLOGY (2006)
Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: A meta-analysis of randomized controlled trials
Jian Shi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Role of nuclear receptors in the adaptive response to bile acids and cholestasis: Pathogenetic and therapeutic considerations
Gernot Zollner et al.
MOLECULAR PHARMACEUTICS (2006)
Pregnancy in autoimmune hepatitis: Outcome and risk factors
C Schramm et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés et al.
GASTROENTEROLOGY (2006)
Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly
AJ Czaja et al.
HEPATOLOGY (2006)
Autoimmune hepatitis, from mechanisms to therapy
MP Manns et al.
HEPATOLOGY (2006)
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice
P Fickert et al.
GASTROENTEROLOGY (2006)
Medical progress: Autoimmune hepatitis
EL Krawitt
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature
Edgardo S. Santos et al.
LIVER INTERNATIONAL (2006)
Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis
Y Miyake et al.
JOURNAL OF HEPATOLOGY (2005)
High-dose ursodeoxycholic acid in primary sclerosing cholangitis:: A 5-year multicenter, randomized, controlled study
R Olsson et al.
GASTROENTEROLOGY (2005)
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis
B Combes et al.
HEPATOLOGY (2005)
Empiric therapy of autoimmune hepatitis with mycophenolate mofetil - Comparison with conventional treatment for refractory disease
AJ Czaja et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus
N Chatur et al.
LIVER INTERNATIONAL (2005)
Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome
JJ Feld et al.
HEPATOLOGY (2005)
Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis:: A three-year randomized trial
H Rautiainen et al.
HEPATOLOGY (2005)
An unusual form of autoimmune hepatitis in young Somalian men
R D'Souza et al.
LIVER INTERNATIONAL (2005)
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
C Corpechot et al.
GASTROENTEROLOGY (2005)
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy
SM Devlin et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: Ten-year results
MM Kaplan et al.
HEPATOLOGY (2004)
Pancreatic Pseudotumor with sclerosing pancreato-cholangitis: Is this a systemic disease?
MN Toosi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis
BA Aqel et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis
D Rost et al.
HEPATOLOGY (2004)
Factors predicting relapse and poor outcome in type I autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission, and plasma cell activity in the liver biopsy
S Verma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Induction of colitis in cftr-/- mice results in bile duct injury
PG Blanco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis
AL Mason et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
M Färkkilä et al.
HEPATOLOGY (2004)
Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis
AJ Czaja et al.
HEPATOLOGY (2004)
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis
C Corpechot et al.
LIVER INTERNATIONAL (2004)
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community
K Bambha et al.
GASTROENTEROLOGY (2003)
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis
JL Siegel et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis
RE Poupon et al.
JOURNAL OF HEPATOLOGY (2003)
Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis
W Hempfling et al.
HEPATOLOGY (2003)
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
DS Pardi et al.
GASTROENTEROLOGY (2003)
When Is Liver Biopsy Needed in the Diagnosis of Primary Biliary Cirrhosis?
Claudia O. Zein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2003)
Risk factors for recurrence of primary sclerosing cholangitis of liver allograft
A Vera et al.
LANCET (2002)
Diagnosis and treatment of autoimmune hepatitis
AJ Czaja et al.
HEPATOLOGY (2002)
Prognosis of symptomatic versus asymptomatic autoimmune hepatitis - A study of 68 patients
J Kogan et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin
T Zolfino et al.
GUT (2002)
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
A Bergquist et al.
JOURNAL OF HEPATOLOGY (2002)
Primary biliary cirrhosis: Incidence and predictive factors of cirrhosis development in ursodiol-treated patients
C Corpechot et al.
GASTROENTEROLOGY (2002)
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
SA Mitchell et al.
GASTROENTEROLOGY (2001)
High serum IgG4 concentrations in patients with sclerosing pancreatitis.
H Hamano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study
GV Gregorio et al.
HEPATOLOGY (2001)
Duration of immunosuppressive therapy in autoimmune hepatitis
S Kanzler et al.
JOURNAL OF HEPATOLOGY (2001)
Management and outcome of pregnancy in autoimmune hepatitis
MA Heneghan et al.
GUT (2001)
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
C Corpechot et al.
HEPATOLOGY (2000)
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
AJ Czaja et al.
GASTROENTEROLOGY (2000)
High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
HR van Buuren et al.
JOURNAL OF HEPATOLOGY (2000)
Wilson's disease with superimposed autoimmune features: Report of two cases and review
P Milkiewicz et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
P Angulo et al.
HEPATOLOGY (2000)
Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
PD Richardson et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
